BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21164203)

  • 1. Potential thresholds for genotoxic effects by micronucleus scoring.
    Elhajouji A; Lukamowicz M; Cammerer Z; Kirsch-Volders M
    Mutagenesis; 2011 Jan; 26(1):199-204. PubMed ID: 21164203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro micronucleus assay with size-classified micronucleus counting to discriminate aneugens from clastogens.
    Hashimoto K; Nakajima Y; Matsumura S; Chatani F
    Toxicol In Vitro; 2010 Feb; 24(1):208-16. PubMed ID: 19747535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miniaturized flow cytometry-based CHO-K1 micronucleus assay discriminates aneugenic and clastogenic modes of action.
    Bryce SM; Avlasevich SL; Bemis JC; Dertinger SD
    Environ Mol Mutagen; 2011 May; 52(4):280-6. PubMed ID: 20872831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometry peripheral blood micronucleus test in vivo: determination of potential thresholds for aneuploidy induced by spindle poisons.
    Cammerer Z; Schumacher MM; Kirsch-Volders M; Suter W; Elhajouji A
    Environ Mol Mutagen; 2010 May; 51(4):278-84. PubMed ID: 19950395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of Aneugens and Clastogens in the In Vitro Micronucleus Test by Kinetochore Scoring Using Automated Image Analysis.
    Wilde S; Queisser N; Holz C; Raschke M; Sutter A
    Environ Mol Mutagen; 2019 Apr; 60(3):227-242. PubMed ID: 30561837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using CTLL-2 and CTLL-2 bcl2 cells to avoid interference by apoptosis in the in vitro micronucleus test.
    Meintières S; Biola A; Pallardy M; Marzin D
    Environ Mol Mutagen; 2003; 41(1):14-27. PubMed ID: 12552588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micronuclei induced by aneugens and clastogens in mononucleate and binucleate cells using the cytokinesis block assay.
    Rosefort C; Fauth E; Zankl H
    Mutagenesis; 2004 Jul; 19(4):277-84. PubMed ID: 15215326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vivo or ex vivo origin of micronuclei measured in human biomonitoring studies.
    Speit G; Zeller J; Neuss S
    Mutagenesis; 2011 Jan; 26(1):107-10. PubMed ID: 21164190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SFTG international collaborative study on in vitro micronucleus test I. General conditions and overall conclusions of the study.
    Lorge E; Thybaud V; Aardema MJ; Oliver J; Wakata A; Lorenzon G; Marzin D
    Mutat Res; 2006 Aug; 607(1):13-36. PubMed ID: 16815079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic investigations of low dose exposures to the genotoxic compounds bisphenol-A and rotenone.
    Johnson GE; Parry EM
    Mutat Res; 2008 Mar; 651(1-2):56-63. PubMed ID: 18083626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a data-processing method based on Bayesian k-means clustering to discriminate aneugens and clastogens in a high-content micronucleus assay.
    Huang ZH; Li N; Rao KF; Liu CT; Huang Y; Ma M; Wang ZJ
    Hum Exp Toxicol; 2018 Mar; 37(3):285-294. PubMed ID: 29233020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of p53 function in different magnitude of genotoxic and cytotoxic responses in in vitro micronucleus assays.
    Hashimoto K; Nakajima Y; Uematsu R; Matsumura S; Chatani F
    Mutat Res; 2011 Nov; 726(1):21-8. PubMed ID: 21855649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro genotoxicity testing using the micronucleus assay in cell lines, human lymphocytes and 3D human skin models.
    Kirsch-Volders M; Decordier I; Elhajouji A; Plas G; Aardema MJ; Fenech M
    Mutagenesis; 2011 Jan; 26(1):177-84. PubMed ID: 21164200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image analysis of mechanistic protein biomarkers for the characterization of genotoxicants: Aneugens, clastogens, and reactive oxygen species inducers.
    Wilde S; Queisser N; Sutter A
    Environ Mol Mutagen; 2020 Jun; 61(5):534-550. PubMed ID: 32297368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpreting in vitro micronucleus positive results: simple biomarker matrix discriminates clastogens, aneugens, and misleading positive agents.
    Bryce SM; Bemis JC; Mereness JA; Spellman RA; Moss J; Dickinson D; Schuler MJ; Dertinger SD
    Environ Mol Mutagen; 2014 Aug; 55(7):542-55. PubMed ID: 24756928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A proposal for a simple way to distinguish aneugens from clastogens in the in vitro micronucleus test.
    Matsuoka A; Matsuura K; Sakamoto H; Hayashi M; Sofuni T
    Mutagenesis; 1999 Jul; 14(4):385-9. PubMed ID: 10390505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommended protocols for the liver micronucleus test: Report of the IWGT working group.
    Uno Y; Morita T; Luijten M; Beevers C; Hamada S; Itoh S; Ohyama W; Takasawa H
    Mutat Res Genet Toxicol Environ Mutagen; 2015 May; 783():13-8. PubMed ID: 25953396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of micronucleus induction and DNA damage biomarkers in TK6 and A375 cells using flow cytometry.
    Sun X; Spellman RA; Engel M; Rubitski E; Schuler M
    Environ Mol Mutagen; 2024; 65(1-2):25-46. PubMed ID: 38333939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the peripheral blood micronucleus test using flow cytometry in rat and mouse exposed to aneugens after single-dose applications.
    Cammerer Z; Elhajouji A; Kirsch-Volders M; Suter W
    Mutagenesis; 2007 Mar; 22(2):129-34. PubMed ID: 17284774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The automated micronucleus assay for early assessment of genotoxicity in drug discovery.
    Tilmant K; Gerets HH; De Ron P; Cossu-Leguille C; Vasseur P; Dhalluin S; Atienzar FA
    Mutat Res; 2013 Feb; 751(1):1-11. PubMed ID: 23159395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.